LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ: OPK) securities between September 26, 2013 through September 7, 2018, inclusive (the “Class Period”). OPKO investors have until November 13, 2018 to file a lead plaintiff motion.
If you are a shareholder who suffered a loss, click here to participate.
On September 7, 2018, the U.S. Securities and Exchange Commission (“SEC”) filed a lawsuit against Opko and its CEO and Chairman Phillip Frost, alleging that Opko and Frost engaged in pump-and-dump schemes. On this news, Opko’s share price fell $1.01 per share, or more than 18%, to close at $4.58 on September 7, 2018, thereby injuring investors.
The complaint filed in this class action alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of OPKO during the Class Period you may move the Court no later than November 13, 2018 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
